MACHINE learning models predicted overall survival and site-specific recurrence in patients with colorectal cancer liver metastases (CRLM) following curative-intent hepatectomy, with dynamic models providing stronger discrimination than baseline models.
The boss of the biggest UK-headquartered tech firm has said that artifical intelligence will find a cure for cancer that humans cannot in our lifetimes.
